Find

Department of Clinical Medicine

HemeLab

Publications

Sort by: Date | Author | Title

Petersen, M. A., Rosenberg, C. A., Brøndum, R. F., Aggerholm, A., Kjeldsen, E., Rahbek, O., Ludvigsen, M., Hasle, H., Roug, A. S. & Bill, M. (2022). Immunophenotypically defined stem cell subsets in paediatric AML are highly heterogeneous and demonstrate differences in BCL-2 expression by cytogenetic subgroups. British Journal of Haematology, 197(4), 452-466. https://doi.org/10.1111/bjh.18094

Petersen, M. A., Rosenberg, C. A., Bill, M., Enemark, M. B., Rahbek, O., Roug, A. S., Hasle, H., Honoré, B. & Ludvigsen, M. (2022). Proteomic Profiling Identifies Specific Leukemic Stem Cell-Associated Protein Expression Patterns in Pediatric AML Patients. Cancers, 14(15), Article 3567. https://doi.org/10.3390/cancers14153567

Pedersen, M. N., Hybel, T. E., Bjerre, J. H., Hammer, A. S. B., Bohn, A. B., Bill, M., Rosenberg, C. A. & Ludvigsen, M. (2025). High-Efficiency Enrichment of Megakaryocytes and Identification of Micromegakaryocytes from Human Bone Marrow by Imaging Flow Cytometry. Cells, 14(8), Article 588. https://doi.org/10.3390/cells14080588

Neldeborg, S., Soerensen, J. F., Møller, C. T., Bill, M., Gao, Z., Bak, R. O., Holm, K., Sorensen, B., Nyegaard, M., Luo, Y., Hokland, P., Stougaard, M., Ludvigsen, M. & Holm, C. K. (2023). Dual intron-targeted CRISPR-Cas9-mediated disruption of the AML RUNX1-RUNX1T1 fusion gene effectively inhibits proliferation and decreases tumor volume in vitro and in vivo. Leukemia, 37(9), 1792-1801. https://doi.org/10.1038/s41375-023-01950-9

Mortensen, J. B., Monrad, I., Enemark, M. B., Ludvigsen, M., Kamper, P., Bjerre, M. & d'Amore, F. (2021). Soluble programmed cell death protein 1 (sPD-1) and the soluble programmed cell death ligands 1 and 2 (sPD-L1 and sPD-L2) in lymphoid malignancies. European Journal of Haematology, 107(1), 81-91. https://doi.org/10.1111/ejh.13621

Monrad, I., Madsen, C., Lauridsen, K. L., Honoré, B., Plesner, T. L., Hamilton-Dutoit, S., D’Amore, F. & Ludvigsen, M. (2020). Glycolytic biomarkers predict transformation in patients with follicular lymphoma. PLoS One, 15(5), Article e0233449. https://doi.org/10.1371/journal.pone.0233449

Møller, M., Rath, M. F., Ludvigsen, M., Honoré, B. & Vorum, H. (2017). Diurnal expression of proteins in the retina of the blind cone-rod homeobox (Crx(-/-) ) mouse and the 129/Sv mouse: a proteomic study. Acta Ophthalmologica, 7(95), 717-726. https://doi.org/10.1111/aos.13429

Meier, M., Andersen, K. J., Knudsen, A. R., Ludvigsen, M., Honoré, B. & Mortensen, F. V. (2016). Extended hepatectomy induces pronounced changes in protein expression levels..

Meier, M., Knudsen, A. R., Andersen, K. J., Ludvigsen, M., Eriksen, P. L., Honoré, B. & Mortensen, F. V. (2019). Upregulation of ureagenesis may be pivotal for survival of post-hepatectomy liver failure in rats. Poster session presented at 13th Congress of the European – African Hepato-Pancreato-Biliary Association, Amsterdam, Netherlands.

Meier, M., Knudsen, A. R., Andersen, K. J., Ludvigsen, M., Honoré, B. & Mortensen, F. V. (2018). Proteomic Characterization of Biological Features in the Small for Size Future Rat Liver Remnant. Poster session presented at 13th IHPBA World Congress, Geneve, Switzerland.

Meier, M., Knudsen, A. R., Andersen, K. J., Ludvigsen, M., Honoré, B. & Mortensen, F. V. (2018). Proteomic Characterization of Biological Features in the Small for Size Future Rat Liver Remnant. Abstract from 13th IHPBA World Congress, Geneve, Switzerland.

Meier, M., Knudsen, A. R., Andersen, K. J., Ludvigsen, M., Lykke Eriksen, P., Pedersen, A. K. N., Honoré, B. & Mortensen, F. V. (2019). Perturbations of urea cycle enzymes during post-hepatectomy rat liver failure. American Journal of Physiology: Gastrointestinal and Liver Physiology, 317(4), G429-G440. https://doi.org/10.1152/ajpgi.00293.2018

Madsen, C., Clausen, M. R., Ludvigsen, M., Plesner, T. L. & D'Amore, F. A. (2016). Upfront Rituximab Maintenance after Induction Therapy Improves Outcome and Reduces the Risk of Histological Transformation in Patients with Follicular Lymphoma – Real World Data form a Danish Population-Based Cohort.

Madsen, C., Clausen, M. R., Plesner, T. L., Pasanen, A., Kuismanen, T., Bentzen, H. H., Jørgensen, J. M., Sillesen, I. B., Himmelstrup, B. M., Rønnov-Jessen, D., Jensen, K. R., Pettinger, A. M., Ludvigsen, M., Leppä, S. & d'Amore, F. A. (2018). Up-front rituximab maintenance improves outcome in patients with follicular lymphoma: a collaborative Nordic study. Blood Advances, 2(13), 1562-1571. https://doi.org/10.1182/bloodadvances.2018017673

Madsen, C., Lauridsen, K. L., Plesner, T. L., Monrad, I., Honoré, B., Hamilton-Dutoit, S., d’Amore, F. & Ludvigsen, M. (2019). High intratumoral expression of vimentin predicts histological transformation in patients with follicular lymphoma. Blood Cancer Journal, 9(4), Article 35. https://doi.org/10.1038/s41408-019-0197-5

Madsen, C., Plesner, T. L., Bentzen, H. H. N., Jørgensen, J. M., Sillesen, I. B., Himmelstrup, B. M., Josefsson, P., Plesner, T., Bennedsen, T. L., Ludvigsen, M. & d'Amore, F. A. (2020). Real world data on histological transformation in patients with follicular lymphoma: incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohort. Leukemia & Lymphoma, 61(11), 2584-2594 . https://doi.org/10.1080/10428194.2020.1779254

MacManus, M. P., Seymour, J. F., Tsang, H., Fisher, R., Keane, C., Sabdia, M. B., Law, S. C., Gunawardana, J., Nath, K., Kazakoff, S. H., Marques-Piubelli, M. L., Duenas, D. E., Green, M. R., Roos, D., O'Brien, P., McCann, A., Tsang, R., Davis, S., Christie, D. ... Tobin, J. W. D. (2024). Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma. EBioMedicine, 110, Article 105468. https://doi.org/10.1016/j.ebiom.2024.105468

Ludvigsen, M., Jacobsen, C., Maunsbach, A. B. & Honoré, B. (2009). Identification and characterization of novel ERC-55 interacting proteins: Evidence for the existence of several ERC-55 splicing variants; including the cytosolic ERC-55-C. Proteomics, 9(23), 5267-5287.

Ludvigsen, M., Ostergaard, M., Vorum, H., Jacobsen, C. & Honoré, B. (2009). Identification and characterization of endonuclein binding proteins: evidence of modulatory effects on signal transduction and chaperone activity. BMC Biochemistry, 10(1), 34. https://doi.org/10.1186/1471-2091-10-34

Ludvigsen, M., Kamper, P., Bendix, K., Hamilton-Dutoit, S. J., Møller, M. B., Rabinovich, G. A., D'Amore, F. A. & Honoré, B. (2010). Outcome-related protein expression profile in patients with classical Hodgkin Lymphoma. Haematologica.

Displaying results 41 to 60 out of 127

3

Revised 11.09.2025

-

Maja Ludvigsen